About Adagrasib API
Therapeutic CategoryAnti-Cancer/ Oncology-pt
CAS Number
2326521-71-3
API Technology
Synthetic
Dose Form
Oral Solid/Tablets
Dr Reddy's Development Status
Under Development
Related APIs
Enzalutamide-pt
Anti-Cancer/ Oncology-pt
Request for Quotation
Get in touch with us by filling out the form below. Our team will reach out to you shortly!